BridgeBio Oncology Therapeutics (BBOT)
Nasdaq • BBOT • US1079241022
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 10.8% of free float sold short, 6.5 days to cover, cost to borrow 1.04%. Sign up for live short interest data.
Market Cap
184m USD | # 7587 in US
Volume
570.27k shares | 3.04m USD
Shares Outstanding
80.17m
Free Float Shares
44.67% | 35.81m
